BIOMARIN PHARMACEUTICAL INC Logo

BIOMARIN PHARMACEUTICAL INC

Develops and commercializes therapies for rare, life-threatening genetic diseases.

BMRN | NDAQ

Overview

Corporate Details

ISIN(s):
US09061G1013
LEI:
Country:
United States of America
Address:
105 DIGITAL DRIVE, 94949 NOVATO
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

BioMarin Pharmaceutical Inc. is a global biotechnology company dedicated to developing and commercializing transformative therapies for rare and life-threatening genetic diseases. Founded in 1997, the company leverages its scientific expertise in the underlying causes of genetic conditions to create first-in-class and best-in-class treatments. Its portfolio of marketed products addresses disorders such as achondroplasia, severe hemophilia A, and various lysosomal storage diseases, often utilizing enzyme replacement therapies (ERTs) and other advanced modalities. BioMarin also maintains an active pipeline of investigational medicines in various stages of clinical and preclinical development to address unmet medical needs.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all BIOMARIN PHARMACEUTICAL INC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for BIOMARIN PHARMACEUTICAL INC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for BIOMARIN PHARMACEUTICAL INC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
EXACT SCIENCES CORP Logo
Provides advanced cancer screening and diagnostic tests for early detection and treatment guidance.
United States of America EXAS
EXELIXIS, INC. Logo
An oncology-focused biotech that discovers and develops medicines for hard-to-treat cancers.
United States of America EXEL
EXICURE, INC. Logo
Develops nucleic acid therapies via its SNA™ platform for neurology, oncology, & genetic diseases.
United States of America XCUR
ExpreS2ion Biotech Holding AB Logo
Clinical-stage biotech developing vaccines and immunotherapies via a proprietary protein platform.
Sweden EXPRS2
EyeGene,Inc Logo
Develops gene/cell therapies & mRNA vaccines for age-related and ocular diseases.
South Korea 185490
EyePoint Pharmaceuticals, Inc. Logo
Develops innovative, sustained-delivery therapeutics for retinal diseases.
United States of America EYPT
Faes Farma S.A. Logo
Develops and markets pharmaceuticals, like antihistamines, and animal nutrition products globally.
Spain FAE
Fagron N.V. Logo
Supplies compounding ingredients and solutions for personalized medicine to healthcare professionals.
Belgium FAGR
Farmak Logo
A pharmaceutical manufacturer and exporter of 400+ medicines to over 50 countries.
Ukraine FARM
Farmsintez ao Logo
Produces APIs & hospital drugs for oncology & specialty diseases; offers contract services.
Russian Federation LIFE

Talk to a Data Expert

Have a question? We'll get back to you promptly.